Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 31)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/AMATK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for MATK: the economy's impact on MATK's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: MARTEK BIOSCIENC -- MATK1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ABII , CELG , ENZN , KNDL , LIFE , MATK , ONTY , VRTX -- DRUGS3$4  View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Martek Biosciences Corporation41$65  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MARTEK BIOSCIENCES CORP5$25  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MARTEK BIOSCIENCES CORP5$25  View Abstract
22-Jan-10Zacks Investment Research Inc.N/AMARTEK BIOSCS (MATK) Zacks Company Snapshot1$10  View Abstract
Next 20
Brokerage Reports (Showing 1 to 2 of 2)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
21-Jan-10Thomson StreetEventsN/AMATK - Event Transcript of Martek Biosciences Corporation conference call, Jan. 21, 2010 / 8:30am ET19$75  View Abstract
21-Jan-10Thomson StreetEventsN/AMATK - Event Brief of Martek Biosciences Corporation conference call, Jan. 21, 2010 / 8:30am ET19$75  View Abstract
Independent Reports (Showing 1 to 10 of 29)
Release
Date [down]		 Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/AMATK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for MATK: the economy's impact on MATK's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: MARTEK BIOSCIENC -- MATK1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ABII , CELG , ENZN , KNDL , LIFE , MATK , ONTY , VRTX -- DRUGS3$4View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Martek Biosciences Corporation41$65View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MARTEK BIOSCIENCES CORP5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MARTEK BIOSCIENCES CORP5$25View Abstract
22-Jan-10Zacks Investment Research Inc.N/AMARTEK BIOSCS (MATK) Zacks Company Snapshot1$10View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.